Phylogenetic and genome-wide deep-sequencing analyses of canine parvovirus reveal co-infection with field variants and emergence of a recent recombinant strain

PLoS One. 2014 Nov 3;9(11):e111779. doi: 10.1371/journal.pone.0111779. eCollection 2014.

Abstract

Canine parvovirus (CPV), a fast-evolving single-stranded DNA virus, comprises three antigenic variants (2a, 2b, and 2c) with different frequencies and genetic variability among countries. The contribution of co-infection and recombination to the genetic variability of CPV is far from being fully elucidated. Here we took advantage of a natural CPV population, recently formed by the convergence of divergent CPV-2c and CPV-2a strains, to study co-infection and recombination. Complete sequences of the viral coding region of CPV-2a and CPV-2c strains from 40 samples were generated and analyzed using phylogenetic tools. Two samples showed co-infection and were further analyzed by deep sequencing. The sequence profile of one of the samples revealed the presence of CPV-2c and CPV-2a strains that differed at 29 nucleotides. The other sample included a minor CPV-2a strain (13.3% of the viral population) and a major recombinant strain (86.7%). The recombinant strain arose from inter-genotypic recombination between CPV-2c and CPV-2a strains within the VP1/VP2 gene boundary. Our findings highlight the importance of deep-sequencing analysis to provide a better understanding of CPV molecular diversity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Base Sequence
  • Dogs
  • Evolution, Molecular*
  • Genome, Viral*
  • Genome-Wide Association Study
  • High-Throughput Nucleotide Sequencing
  • Molecular Sequence Data
  • Parvovirus, Canine / genetics*
  • Phylogeny*
  • Recombination, Genetic*

Associated data

  • GENBANK/KM457102
  • GENBANK/KM457103
  • GENBANK/KM457104
  • GENBANK/KM457105
  • GENBANK/KM457106
  • GENBANK/KM457107
  • GENBANK/KM457108
  • GENBANK/KM457109
  • GENBANK/KM457110
  • GENBANK/KM457111
  • GENBANK/KM457112
  • GENBANK/KM457113
  • GENBANK/KM457114
  • GENBANK/KM457115
  • GENBANK/KM457116
  • GENBANK/KM457117
  • GENBANK/KM457118
  • GENBANK/KM457119
  • GENBANK/KM457120
  • GENBANK/KM457121
  • GENBANK/KM457122
  • GENBANK/KM457123
  • GENBANK/KM457124
  • GENBANK/KM457125
  • GENBANK/KM457126
  • GENBANK/KM457127
  • GENBANK/KM457128
  • GENBANK/KM457129
  • GENBANK/KM457130
  • GENBANK/KM457131
  • GENBANK/KM457132
  • GENBANK/KM457133
  • GENBANK/KM457134
  • GENBANK/KM457135
  • GENBANK/KM457136
  • GENBANK/KM457137
  • GENBANK/KM457138
  • GENBANK/KM457139
  • GENBANK/KM457140
  • GENBANK/KM457141
  • GENBANK/KM457142
  • GENBANK/KM457143

Grants and funding

Grant number: 2206, Comisión Sectorial de Investigación Científica (CSIC) (http://www.csic.edu.uy/) to KS. Grant number ANR-10-LABX-62-IBEID, French Investissement d'Avenir program, Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases (http://www.agence-nationale-recherche.fr/investissementsdavenir/) to MV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.